Yun Zhang
Directeur/Membre du Conseil chez CHINA INTERNATIONAL HOLDINGS LIMITED
Profil
Yun Zhang is currently an Independent Director at China International Holdings Ltd., a Director at Jiangsu Huatai Chenguang Pharmaceutical Co., Ltd., and a Founding Partner at Shenzhen Riverbed Yucheng Private Equity Investment Enterprise.
Previously, Mr. Zhang worked as a Director at Beijing Tivani Medical Technology Co. Ltd.
Mr. Zhang completed their graduate degree at Peking University and their undergraduate degree at Sun Yat-Sen University.
Postes actifs de Yun Zhang
| Sociétés | Poste | Début |
|---|---|---|
| CHINA INTERNATIONAL HOLDINGS LIMITED | Directeur/Membre du Conseil | 01/12/2023 |
Jiangsu Huatai Chenguang Pharmaceutical Co., Ltd.
 Jiangsu Huatai Chenguang Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Jiangsu Huatai Chenguang Pharmaceutical Co., Ltd. was founded in 2010 and is based in Taizhou, China. The Chinese company focuses on the exploration and research of high-barrier generic drugs for perioperative and tumor pain management, as well as the development of improved new drugs with significant technological advancements and application prospects, using leading global drug delivery technologies to provide patients with more and better drug choices. The company also produces a trademarked drug called Pusiding, which is a combination of hydrocodone bitartrate and acetaminophen used for pain relief. | Directeur/Membre du Conseil | - |
Anciens postes connus de Yun Zhang
| Sociétés | Poste | Fin |
|---|
Formation de Yun Zhang
| Peking University | Graduate Degree |
| Sun Yat-Sen University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CHINA INTERNATIONAL HOLDINGS LIMITED | Finance |
| Entreprise privées | 1 |
|---|---|
Jiangsu Huatai Chenguang Pharmaceutical Co., Ltd.
Jiangsu Huatai Chenguang Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Jiangsu Huatai Chenguang Pharmaceutical Co., Ltd. was founded in 2010 and is based in Taizhou, China. The Chinese company focuses on the exploration and research of high-barrier generic drugs for perioperative and tumor pain management, as well as the development of improved new drugs with significant technological advancements and application prospects, using leading global drug delivery technologies to provide patients with more and better drug choices. The company also produces a trademarked drug called Pusiding, which is a combination of hydrocodone bitartrate and acetaminophen used for pain relief. | Health Technology |